$DXCM
Price history, market instrument context, member research, and related headlines in one place.
DXCM key statistics
DexCom, Inc. (DXCM) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $87.71, up $4.24 (5.08%) from the previous close of $83.47. It has traded between $85.43 and $87.88 in the latest session. Over the past year it has ranged from $54.11 to $92.59, leaving it in the upper quarter of its 52-week range (87%). Reported volume for the session was 4.5M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Related news
DexCom stock hits 52-week high at 91.99 USD — See source for full details.
July healthcare recap: Regeneron, DexCom shine as Moderna, managed-care stocks retreat — See source for full details.
Following the release of its Q2 results on 30 July, Dexcom
BTIG raises DexCom stock price target to $90 on strong Q2 results — See source for full details.
Dexcom lifts 2026 revenue outlook to $5.18B-$5.25B as it targets nearly 50% U.S. G7 15 Day conversion by year-end — See source for full details.
DexCom rises on Q2 beats, raised 2026 revenue guidance midpoint — See source for full details.
Dexcom Q2 2026 slides: strong beat drives guidance raise, margins expand — See source for full details.